2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

doi:10.1093/eurheartj/ehz455

. 2020 Jan 1;41(1):111-188.

doi: 10.1093/eurheartj/ehz455.

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

Collaborators

ESC Scientific Document Group:
Christian Mueller, Heinz Drexel, Victor Aboyans, Alberto Corsini, Wolfram Doehner, Michel Farnier, Bruna Gigante, Meral Kayikcioglu, Goran Krstacic, Ekaterini Lambrinou, Basil S Lewis, Josep Masip, Philippe Moulin, Steffen Petersen, Anna Sonia Petronio, Massimo Francesco Piepoli, Xavier Pintó, Lorenz Räber, Kausik K Ray, Željko Reiner, Walter F Riesen, Marco Roffi, Jean-Paul Schmid, Evgeny Shlyakhto, Iain A Simpson, Erik Stroes, Isabella Sudano, Alexandros D Tselepis, Margus Viigimaa, Cecile Vindis, Alexander Vonbank, Michal Vrablik, Mislav Vrsalovic, José Luis Zamorano, Jean-Philippe Collet, Konstantinos C Koskinas, Manuela Casula, Lina Badimon, M John Chapman, Guy G De Backer, Victoria Delgado, Brian A Ference, Ian M Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R Pedersen, Gabriele Riccardi, Dimitrios J Richter, Marc S Sabatine, Marja-Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund, Stephan Windecker, Victor Aboyans, Colin Baigent, Jean-Philippe Collet, Veronica Dean, Victoria Delgado, Donna Fitzsimons, Chris P Gale, Diederick Grobbee, Sigrun Halvorsen, Gerhard Hindricks, Bernard Iung, Peter Jüni, Hugo A Katus, Ulf Landmesser, Christophe Leclercq, Maddalena Lettino, Basil S Lewis, Bela Merkely, Christian Mueller, Steffen Petersen, Anna Sonia Petronio, Dimitrios J Richter, Marco Roffi, Evgeny Shlyakhto, Iain A Simpson, Miguel Sousa-Uva, Rhian M Touyz, Djamaleddine Nibouche, Parounak H Zelveian, Peter Siostrzonek, Ruslan Najafov, Philippe van de Borne, Belma Pojskic, Arman Postadzhiyan, Lambros Kypris, Jindřich Špinar, Mogens Lytken Larsen, Hesham Salah Eldin, Margus Viigimaa, Timo E Strandberg, Jean Ferrières, Rusudan Agladze, Ulrich Laufs, Loukianos Rallidis, László Bajnok, Thorbjörn Gudjónsson, Vincent Maher, Yaakov Henkin, Michele Massimo Gulizia, Aisulu Mussagaliyeva, Gani Bajraktari, Alina Kerimkulova, Gustavs Latkovskis, Omar Hamoui, Rimvydas Slapikas, Laurent Visser, Philip Dingli, Victoria Ivanov, Aneta Boskovic, Mbarek Nazzi, Frank Visseren, Irena Mitevska, Kjetil Retterstøl, Piotr Jankowski, Ricardo Fontes-Carvalho, Dan Gaita, Marat Ezhov, Marina Foscoli, Vojislav Giga, Daniel Pella, Zlatko Fras, Leopoldo Perez de Isla, Emil Hagström, Roger Lehmann, Leila Abid, Oner Ozdogan, Olena Mitchenko, Riyaz S Patel

PMID: 31504418
DOI: 10.1093/eurheartj/ehz455

Free article

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

François Mach et al. Eur Heart J. 2020.

Free article

. 2020 Jan 1;41(1):111-188.

doi: 10.1093/eurheartj/ehz455.

Collaborators

ESC Scientific Document Group:
Christian Mueller, Heinz Drexel, Victor Aboyans, Alberto Corsini, Wolfram Doehner, Michel Farnier, Bruna Gigante, Meral Kayikcioglu, Goran Krstacic, Ekaterini Lambrinou, Basil S Lewis, Josep Masip, Philippe Moulin, Steffen Petersen, Anna Sonia Petronio, Massimo Francesco Piepoli, Xavier Pintó, Lorenz Räber, Kausik K Ray, Željko Reiner, Walter F Riesen, Marco Roffi, Jean-Paul Schmid, Evgeny Shlyakhto, Iain A Simpson, Erik Stroes, Isabella Sudano, Alexandros D Tselepis, Margus Viigimaa, Cecile Vindis, Alexander Vonbank, Michal Vrablik, Mislav Vrsalovic, José Luis Zamorano, Jean-Philippe Collet, Konstantinos C Koskinas, Manuela Casula, Lina Badimon, M John Chapman, Guy G De Backer, Victoria Delgado, Brian A Ference, Ian M Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R Pedersen, Gabriele Riccardi, Dimitrios J Richter, Marc S Sabatine, Marja-Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund, Stephan Windecker, Victor Aboyans, Colin Baigent, Jean-Philippe Collet, Veronica Dean, Victoria Delgado, Donna Fitzsimons, Chris P Gale, Diederick Grobbee, Sigrun Halvorsen, Gerhard Hindricks, Bernard Iung, Peter Jüni, Hugo A Katus, Ulf Landmesser, Christophe Leclercq, Maddalena Lettino, Basil S Lewis, Bela Merkely, Christian Mueller, Steffen Petersen, Anna Sonia Petronio, Dimitrios J Richter, Marco Roffi, Evgeny Shlyakhto, Iain A Simpson, Miguel Sousa-Uva, Rhian M Touyz, Djamaleddine Nibouche, Parounak H Zelveian, Peter Siostrzonek, Ruslan Najafov, Philippe van de Borne, Belma Pojskic, Arman Postadzhiyan, Lambros Kypris, Jindřich Špinar, Mogens Lytken Larsen, Hesham Salah Eldin, Margus Viigimaa, Timo E Strandberg, Jean Ferrières, Rusudan Agladze, Ulrich Laufs, Loukianos Rallidis, László Bajnok, Thorbjörn Gudjónsson, Vincent Maher, Yaakov Henkin, Michele Massimo Gulizia, Aisulu Mussagaliyeva, Gani Bajraktari, Alina Kerimkulova, Gustavs Latkovskis, Omar Hamoui, Rimvydas Slapikas, Laurent Visser, Philip Dingli, Victoria Ivanov, Aneta Boskovic, Mbarek Nazzi, Frank Visseren, Irena Mitevska, Kjetil Retterstøl, Piotr Jankowski, Ricardo Fontes-Carvalho, Dan Gaita, Marat Ezhov, Marina Foscoli, Vojislav Giga, Daniel Pella, Zlatko Fras, Leopoldo Perez de Isla, Emil Hagström, Roger Lehmann, Leila Abid, Oner Ozdogan, Olena Mitchenko, Riyaz S Patel

PMID: 31504418
DOI: 10.1093/eurheartj/ehz455

Erratum in

Corrigendum to: 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
[No authors listed] [No authors listed] Eur Heart J. 2020 Nov 21;41(44):4255. doi: 10.1093/eurheartj/ehz826. Eur Heart J. 2020. PMID: 31837134 No abstract available.

No abstract available

Keywords: Guidelines; apolipoprotein B; cholesterol; dyslipidaemias; familial hypercholesterolaemia; high-density lipoproteins; lipoprotein remnants; lipoprotein(a); low-density lipoproteins; total cardiovascular risk; treatment (adherence); treatment (drugs); treatment (lifestyle); triglycerides; very low-density lipoproteins.

PubMed Disclaimer

Comment in

Do we need a redefinition of the cardiovascular risk categories used in the 2019 ESC/EAS guidelines on dyslipidaemias?
Gragnano F, Calabrò P. Gragnano F, et al. Eur Heart J. 2020 Jun 21;41(24):2332. doi: 10.1093/eurheartj/ehz940. Eur Heart J. 2020. PMID: 32031600 No abstract available.
A clinical perspective on the 2019 ESC/EAS guidelines for the management of dyslipidaemias: PCSK-9 inhibitors for all?
Dykun I, Mahabadi AA, Rassaf T. Dykun I, et al. Eur Heart J. 2020 Jun 21;41(24):2331. doi: 10.1093/eurheartj/ehaa005. Eur Heart J. 2020. PMID: 32031601 No abstract available.
Comments on the 2019 ESC/EAS guidelines for the management of dyslipidemias.
SEC Working Group for the 2019 ESC EAS guidelines for the management of dyslipidaemias, Expert Reviewers for the 2019 ESC guidelines for the management of dyslipidaemias, SEC Guidelines Committe; Grupo de Trabajo de la SEC para la guía ESC 2019 sobre el tratamiento de las dislipemias; Revisores expertos para la ESC 2019 sobre el tratamiento de las dislipemias; Comité de Guías de la SEC. SEC Working Group for the 2019 ESC EAS guidelines for the management of dyslipidaemias, Expert Reviewers for the 2019 ESC guidelines for the management of dyslipidaemias, SEC Guidelines Committe, et al. Rev Esp Cardiol (Engl Ed). 2020 May;73(5):348-353. doi: 10.1016/j.rec.2019.11.019. Epub 2020 Mar 21. Rev Esp Cardiol (Engl Ed). 2020. PMID: 32205101 English, Spanish. No abstract available.
Targeting LDL cholesterol: Early treatment is key to population health.
Stock J. Stock J. Atherosclerosis. 2020 May;300:37-38. doi: 10.1016/j.atherosclerosis.2020.03.013. Epub 2020 Mar 31. Atherosclerosis. 2020. PMID: 32253009 No abstract available.

Cited by

The functions of apolipoproteins and lipoproteins in health and disease.
Ma Z, Zhong J, Tu W, Li S, Chen J. Ma Z, et al. Mol Biomed. 2024 Oct 28;5(1):53. doi: 10.1186/s43556-024-00218-7. Mol Biomed. 2024. PMID: 39465476 Free PMC article. Review.
Effect of Statin Treatment on Lipoprotein-Associated Phospholipase A2 Mass and Activity: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials.
Sahebkar A, Reiner Ž, Almahmeed W, Jamialahmadi T, Simental-Mendía LE. Sahebkar A, et al. Cardiovasc Drugs Ther. 2024 Oct 28. doi: 10.1007/s10557-024-07634-5. Online ahead of print. Cardiovasc Drugs Ther. 2024. PMID: 39466484 Review.
In search of the pleiotropic effects of PCSK9 inhibitors.
Räber L, Ueki Y. Räber L, et al. EuroIntervention. 2022 Oct 7;18(8):e609-e610. doi: 10.4244/EIJ-E-22-00032. EuroIntervention. 2022. PMID: 36205734 Free PMC article. No abstract available.
The association of remnant cholesterol (RC) and interaction between RC and diabetes on the subsequent risk of hypertension.
Wang J, Sun Q, An Y, Liu J, Leng S, Wang G. Wang J, et al. Front Endocrinol (Lausanne). 2022 Aug 25;13:951635. doi: 10.3389/fendo.2022.951635. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36093110 Free PMC article.
Serum LDL-C/HDL-C ratio and the risk of carotid plaques: a longitudinal study.
Wu Z, Li X, Wen Q, Tao B, Qiu B, Zhang Q, Wang J. Wu Z, et al. BMC Cardiovasc Disord. 2022 Nov 24;22(1):501. doi: 10.1186/s12872-022-02942-w. BMC Cardiovasc Disord. 2022. PMID: 36434516 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

Collaborators

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

Authors

Collaborators

Erratum in

Comment in

Similar articles

Cited by

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Erratum in

Comment in

Similar articles

Cited by

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical